skip to content
Primary navigation


Drug - Extina® (ketoconazole) 2% foam [Stiefel Labs]

October 2008

Therapeutic area - Dermatology


Extina is indicated for the topical treatment of seborrheic dermatitis in patients 12 years of age and older.


ketoconazole foam 2% for topical use

Supplied AWP/container
50 gm $155
100 gm $288.75


  • Patients have seborrheic dermatitis AND
  • Patients have not had adequate response to topical terbinafine or topical sodium sulfacetamide AND
  • Patient or caregiver CAN NOT use a ketoconazole cream (for body) or shampoo (for scalp) formulation and the physician or pharmacist provides rationale for use of a foam formulation AND
  • Patient or caregiver is made aware that Extina Foam is flammable and special precautions are required during its handling

Extina Foam Information for Patients

  • Do not spray Extina Foam near fire or direct heat. Never throw the can into a fire, even if the can is empty.
  • Store the can of Extina Foam at room temperature, 68° to 77°F (20°-25°C). Do not place the Extina Foam can in the refrigerator or freezer.
  • Keep the Extina Foam can away from all sources of fire and heat. Do not leave the Extina Foam can in direct sunlight.
  • Do not smoke while holding the Extina Foam can or while spraying or applying the foam.


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top